V B Kraus1, G McDaniel2, J L Huebner3, T V Stabler3, C F Pieper4, S W Shipes5, N A Petry6, P S Low7, J Shen8, T A McNearney8, P Mitchell8. 1. Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA; Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address: vbk@duke.edu. 2. Department of Medicine, Duke University School of Medicine, Durham, NC, USA. 3. Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA. 4. Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA. 5. Division of Nuclear Medicine, Department of Radiology, Duke University School of Medicine, Durham, NC, USA. 6. Department of Radiology, The Medical Physics Program and Nuclear Medicine, Duke University School of Medicine, Durham, NC, USA. 7. Department of Chemistry, Purdue University, West Lafayette, IN, USA. 8. Eli Lilly and Company, Indianapolis, IN, USA.
Abstract
OBJECTIVE: Through binding to folate receptor-β (FR-β), the new (99m)Tc-EC20 (Etarfolatide) imaging technique detects activated but not resting macrophages in vivo. The goal of this study was to investigate macrophage-related inflammation in osteoarthritis (OA). METHODS: Twenty-five individuals (50 knees) with symptomatic OA of at least one knee underwent SPECT-CT imaging of both knees and planar imaging of the whole body after injection of Etarfolatide. Scans and knee radiographs were scored blinded to clinical information including knee and other joint site pain severity. Measures of association controlled for age, gender, body mass index (BMI) and employed repeated measures to adjust for correlation between knees. DESIGN: Activated macrophages were present in the majority (76%) of knees. The quantity of knee-related macrophages was significantly associated with knee pain severity (R = 0.60, P < 0.0001) and radiographic knee OA severity including joint space narrowing (R = 0.68, P = 0.007), and osteophyte (R = 0.66, P = 0.001). Macrophages were also localized to joints commonly affected by OA including hand finger joints (12%), thumb bases (28%), shoulders (26%), great toes (18%) and ankles (12%). The presence of joint pain at fingers, wrists, ankles and great toes was significantly positively associated with presence of activated macrophages at these sites (P < 0.0001-0.04). CONCLUSIONS: This study provides the first direct in vivo evidence for macrophage involvement in OA in a substantial proportion of human knees. The association of quantity of activated macrophages with radiographic knee OA severity and joint symptoms suggests that drugs targeting macrophages and macrophage-associated inflammatory pathways may have the potential to be both symptom and structure modifying.
OBJECTIVE: Through binding to folate receptor-β (FR-β), the new (99m)Tc-EC20 (Etarfolatide) imaging technique detects activated but not resting macrophages in vivo. The goal of this study was to investigate macrophage-related inflammation in osteoarthritis (OA). METHODS: Twenty-five individuals (50 knees) with symptomatic OA of at least one knee underwent SPECT-CT imaging of both knees and planar imaging of the whole body after injection of Etarfolatide. Scans and knee radiographs were scored blinded to clinical information including knee and other joint site pain severity. Measures of association controlled for age, gender, body mass index (BMI) and employed repeated measures to adjust for correlation between knees. DESIGN: Activated macrophages were present in the majority (76%) of knees. The quantity of knee-related macrophages was significantly associated with knee pain severity (R = 0.60, P < 0.0001) and radiographic knee OA severity including joint space narrowing (R = 0.68, P = 0.007), and osteophyte (R = 0.66, P = 0.001). Macrophages were also localized to joints commonly affected by OA including hand finger joints (12%), thumb bases (28%), shoulders (26%), great toes (18%) and ankles (12%). The presence of joint pain at fingers, wrists, ankles and great toes was significantly positively associated with presence of activated macrophages at these sites (P < 0.0001-0.04). CONCLUSIONS: This study provides the first direct in vivo evidence for macrophage involvement in OA in a substantial proportion of human knees. The association of quantity of activated macrophages with radiographic knee OA severity and joint symptoms suggests that drugs targeting macrophages and macrophage-associated inflammatory pathways may have the potential to be both symptom and structure modifying.
Authors: Nynke A Jager; Johanna Westra; Reza Golestani; Gooitzen M van Dam; Philip S Low; René A Tio; Riemer H J A Slart; Hendrikus H Boersma; Marc Bijl; Clark J Zeebregts Journal: J Nucl Med Date: 2014-10-30 Impact factor: 10.057
Authors: Amaya Puig-Kröger; Elena Sierra-Filardi; Angeles Domínguez-Soto; Rafael Samaniego; María Teresa Corcuera; Fernando Gómez-Aguado; Manohar Ratnam; Paloma Sánchez-Mateos; Angel L Corbí Journal: Cancer Res Date: 2009-12-15 Impact factor: 12.701
Authors: Joost W van der Heijden; Ruud Oerlemans; Ben A C Dijkmans; Huiling Qi; Conny J van der Laken; Willem F Lems; Ann L Jackman; Maarten C Kraan; Paul P Tak; Manohar Ratnam; Gerrit Jansen Journal: Arthritis Rheum Date: 2009-01
Authors: Keiko Amano; Janet L Huebner; Thomas V Stabler; Matthew Tanaka; Charles E McCulloch; Iryna Lobach; Nancy E Lane; Virginia B Kraus; C Benjamin Ma; Xiaojuan Li Journal: Am J Sports Med Date: 2018-01-24 Impact factor: 6.202
Authors: Shanshan Li; Ann V Schwartz; Michael P LaValley; Na Wang; Nancy Desai; Xianbang Sun; Tuhina Neogi; Michael Nevitt; Cora E Lewis; Ali Guermazi; Frank Roemer; Neil Segal; David Felson Journal: Arthritis Rheumatol Date: 2020-05-28 Impact factor: 10.995